Kazuya Hosokawa

9PUBLICATIONS
39CO-AUTHORS
Respiratory diseasesHaematological tumoursPacific Peoples theory of change models for healthPsychology of ageing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 01, 2026
The Role of Medical Therapy Before and After Balloon Pulmonary Angioplasty: CTEPH AC Registry Across Japan.

|Jun 11, 2026
Facilitating early diagnosis of chronic thromboembolic pulmonary hypertension with dynamic chest radiography: Protocol for a multicenter, assessor-blinded, case-wise randomized superiority reader study (FIND-DCR).

|Mar 12, 2026
Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial.

Keimei Yoshida, Kazuya Hosokawa, Takahiro Hiraide

|Nov 17, 2025
Effects of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors on Relationship Between B-Type Natriuretic Peptide and Hemoglobin Levels in Patients With Cardiorenal Anemia Syndrome.

Tomoaki Yoshitake, Toru Hashimoto, Shouji Matsushima

|Jun 13, 2025
Activated factor X inhibition ameliorates NF-κB-IL-6-mediated perivascular inflammation and pulmonary hypertension.

Satomi Imakiire, Keiji Kimuro, Keimei Yoshida

|Dec 17, 2024
Development and Validation of Quality Indicators for Pulmonary Arterial Hypertension Management in Japan: A Modified Delphi Consensus Study.

Yuichi Tamura, Kazuya Hosokawa, Koshin Horimoto

Pageof 2

Frequent Collaborators

3 joint publications

Kohei Masaki

3 joint publications

Yuichi Tamura

2 joint publications

Yoshihiro Fukumoto

2 joint publications

Koshin Horimoto